J&J to Separate Prescription Drugs Business From OTC Consumer Products

Johnson & Johnson (J&J) plans to spin off its over-the-counter consumer products unit from its more lucrative prescription drugs and medical devices division, splitting itself into two publicly traded companies within the next 18 to 24 months.
Source: Drug Industry Daily